Compare J.B.Chemicals with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PIRAMAL ENTERPRISES - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PIRAMAL ENTERPRISES J.B.CHEMICALS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 16.9 17.0 99.7% View Chart
P/BV x 2.3 1.1 207.2% View Chart
Dividend Yield % 0.5 1.6 32.0%  

Financials

 J.B.CHEMICALS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PIRAMAL ENTERPRISES
Mar-19
J.B.CHEMICALS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3633,303 11.0%   
Low Rs2551,797 14.2%   
Sales per share (Unadj.) Rs169.1716.5 23.6%  
Earnings per share (Unadj.) Rs16.679.7 20.8%  
Cash flow per share (Unadj.) Rs23.4107.9 21.7%  
Dividends per share (Unadj.) Rs2.0028.00 7.1%  
Dividend yield (eoy) %0.61.1 58.9%  
Book value per share (Unadj.) Rs172.51,477.5 11.7%  
Shares outstanding (eoy) m83.57184.45 45.3%   
Bonus/Rights/Conversions BBIS-  
Price / Sales ratio x1.83.6 51.3%   
Avg P/E ratio x18.632.0 58.2%  
P/CF ratio (eoy) x13.223.6 55.9%  
Price / Book Value ratio x1.81.7 103.8%  
Dividend payout %12.035.1 34.3%   
Avg Mkt Cap Rs m25,827470,292 5.5%   
No. of employees `0003.87.8 48.2%   
Total wages/salary Rs m2,51122,504 11.2%   
Avg. sales/employee Rs Th3,747.416,899.4 22.2%   
Avg. wages/employee Rs Th665.72,877.7 23.1%   
Avg. net profit/employee Rs Th367.81,879.9 19.6%   
INCOME DATA
Net Sales Rs m14,135132,153 10.7%  
Other income Rs m3663,128 11.7%   
Total revenues Rs m14,501135,281 10.7%   
Gross profit Rs m2,17866,290 3.3%  
Depreciation Rs m5705,202 11.0%   
Interest Rs m3544,097 0.1%   
Profit before tax Rs m1,94020,119 9.6%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5528,611 6.4%   
Profit after tax Rs m1,38714,701 9.4%  
Gross profit margin %15.450.2 30.7%  
Effective tax rate %28.542.8 66.5%   
Net profit margin %9.811.1 88.2%  
BALANCE SHEET DATA
Current assets Rs m10,470122,742 8.5%   
Current liabilities Rs m2,749310,810 0.9%   
Net working cap to sales %54.6-142.3 -38.4%  
Current ratio x3.80.4 964.4%  
Inventory Days Days5523 239.3%  
Debtors Days Days7839 199.9%  
Net fixed assets Rs m5,811116,904 5.0%   
Share capital Rs m167369 45.3%   
"Free" reserves Rs m14,248272,161 5.2%   
Net worth Rs m14,416272,530 5.3%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m17,649856,261 2.1%  
Interest coverage x56.61.5 3,884.9%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.80.2 518.9%   
Return on assets %8.16.9 117.3%  
Return on equity %9.65.4 178.4%  
Return on capital %13.712.4 110.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16415,200 40.6%   
Fx outflow Rs m1,3344,889 27.3%   
Net fx Rs m4,82910,312 46.8%   
CASH FLOW
From Operations Rs m1,231-115,975 -1.1%  
From Investments Rs m-208-8,265 2.5%  
From Financial Activity Rs m-595107,525 -0.6%  
Net Cashflow Rs m427-16,650 -2.6%  

Share Holding

Indian Promoters % 55.4 52.9 104.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.0 84.8%  
FIIs % 3.9 26.6 14.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 16.5 224.2%  
Shareholders   30,437 93,274 32.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   UNICHEM LAB  VENUS REMEDIES  PFIZER  FDC LTD.  SHASUN PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Nov 11, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - SANOFI INDIA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS